Takip et
Saoirse O'Sullivan
Saoirse O'Sullivan
CanPharmaConsulting
Doğrulanmış e-posta adresi yok
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors
SE O'sullivan
British journal of pharmacology 152 (5), 576-582, 2007
6582007
A systematic review on the pharmacokinetics of cannabidiol in humans
SA Millar, NL Stone, AS Yates, SE O'Sullivan
Frontiers in pharmacology 9, 425858, 2018
5572018
An update on PPAR activation by cannabinoids
SE O'Sullivan
British journal of pharmacology 173 (12), 1899-1910, 2016
4972016
Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease
SE O'Sullivan, DA Kendall
Immunobiology 215 (8), 611-616, 2010
3102010
Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled …
KA Jadoon, SH Ratcliffe, DA Barrett, EL Thomas, C Stott, JD Bell, ...
Diabetes care 39 (10), 1777-1786, 2016
2762016
A systematic review of cannabidiol dosing in clinical populations
SA Millar, NL Stone, ZD Bellman, AS Yates, TJ England, SE O'Sullivan
British journal of clinical pharmacology 85 (9), 1888-1900, 2019
2542019
A novel transwell blood brain barrier model using primary human cells
NL Stone, TJ England, SE O’Sullivan
Frontiers in cellular neuroscience 13, 230, 2019
2492019
Towards better delivery of cannabidiol (CBD)
SA Millar, RF Maguire, AS Yates, SE O’Sullivan
Pharmaceuticals 13 (9), 219, 2020
2232020
Time-dependent vascular actions of cannabidiol in the rat aorta
SE O'Sullivan, Y Sun, AJ Bennett, MD Randall, DA Kendall
European journal of pharmacology 612 (1-3), 61-68, 2009
2162009
The complexities of the cardiovascular actions of cannabinoids
MD Randall, DA Kendall, S O'Sullivan
British journal of pharmacology 142 (1), 20-26, 2004
1952004
RECAST (remote ischemic conditioning after stroke trial) a pilot randomized placebo controlled phase II trial in acute ischemic stroke
TJ England, A Hedstrom, S O’Sullivan, R Donnelly, DA Barrett, S Sarmad, ...
Stroke 48 (5), 1412-1415, 2017
1942017
Cannabidiol protects an in vitro model of the blood–brain barrier from oxygen‐glucose deprivation via PPARγ and 5‐HT1A receptors
WH Hind, TJ England, SE O'Sullivan
British journal of pharmacology 173 (5), 815-825, 2016
1872016
Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma
SE O’Sullivan, EJ Tarling, AJ Bennett, DA Kendall, MD Randall
Biochemical and biophysical research communications 337 (3), 824-831, 2005
1862005
The effects of exercise and training on human cardiovascular reflex control
SE O’Sullivan, C Bell
Journal of the Autonomic Nervous System 81 (1-3), 16-24, 2000
1752000
A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study
KA Jadoon, GD Tan, SE O’Sullivan
JCI insight 2 (12), e93760, 2017
1732017
Is the cardiovascular system a therapeutic target for cannabidiol?
CP Stanley, WH Hind, SE O'Sullivan
British journal of clinical pharmacology 75 (2), 313-322, 2013
1622013
Cannabinoids mediate opposing effects on inflammation‐induced intestinal permeability
A Alhamoruni, KL Wright, M Larvin, SE O'sullivan
British journal of pharmacology 165 (8), 2598-2610, 2012
1552012
Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability
A Alhamoruni, AC Lee, KL Wright, M Larvin, SE O’sullivan
The Journal of Pharmacology and Experimental Therapeutics 335 (1), 92-102, 2010
1372010
Vascular targets for cannabinoids: animal and human studies
C Stanley, SE O'Sullivan
British journal of pharmacology 171 (6), 1361-1378, 2014
1332014
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation
CP Stanley, WH Hind, C Tufarelli, SE O'Sullivan
Cardiovascular research 107 (4), 568-578, 2015
1172015
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20